Huma Acquires German CRO Alcedis
Huma Therapeutics Limited, a global digital health company, announced on January 9 its acquisition of Alcedis GmbH for an undisclosed price. Through the acquisition, Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline, from early stage through to Phase IV hybrid and fully decentralized trials. Alcedis GmbH is a contract research organization (CRO) for data driven clinical research and technology utilization. Headquartered in Hessen, Germany, Alcedis has more than 25 years of clinical trial experience. Huma Therapeutics produces applications that integrate health data from hospital databases as well as patient wearables and... Read More »
Hillhouse Acquires CRO George Clinical
George Clinical announced on December 9 that it has entered into a sale agreement with Hillhouse, a Beijing-based global investment firm with deep experience in partnering with and supporting healthcare businesses. The George Institute will hold a minority stake in George Clinical following the acquisition and will maintain a collaboration in applicable scientific areas such as in the Global Kidney Patients Trials Network. BofA Securities acted as lead financial advisor on the transaction and Lazard Australia acted as co-advisor. Herbert Smith Freehills LLP acted as legal advisor on the transaction. Financial terms of the transaction were not disclosed. George Clinical is a global clinical... Read More »
Arlington Capital Partners’s Everest Clinical Research Acquires Brightech International
Everest Clinical Research, an Arlington Capital Partners portfolio company, announced on December 1 its acquisition of Brightech International. Brightech will continue to be led by Dr. Tai Xie, the company’s CEO and founder, and the existing management team. Terms of the deal were not disclosed. Founded in 2002, Brightech International is a contract research organization (CRO) that specializes in complex, value-add biostatistics, programming and clinical data management services. Like Everest, Brightech has built a reputation as a critical partner for some of the world’s largest pharmaceutical and biotech companies. In addition to its New Jersey headquarters, Brightech has an expanded... Read More »
Reaction Biology Acquires vivoPharm
Malvern, Pennsylvania-based Reaction Biology has acquired Hummelstown, Pennsylvania-based vivoPharm LLC from Vyant Bio, Inc. Terms of the deal were not disclosed. Founded in 2001, Reaction Biology is a contract research organization that has provided drug discovery and development services to more than 1,800 biopharmaceutical customers worldwide. Reaction has laboratory facilities in Malvern and Hershey, Pennsylvania, and Freiburg, Germany, with approximately 170 employees. vivoPharm is a contract research organization that offers integrated preclinical services in different disease areas to the biotechnology and pharmaceutical industries. According to the LevinPro HC database, this was... Read More »